Call for Applications: Alliance for Lupus Research Target Identification in Lupus Grants
GRANT DUE DATE: August 1, 2013
The Alliance for Lupus Research (ALR) is pleased to announce that the applications for the ALR’s Target Identification in Lupus (TIL) grants are now available online on the ALR's website. The guidelines and application are also available through the Altum proposalCENTRAL website at https://proposalcentral.altum.com and then search for the ALR’s Target Identification in Lupus program application.
Funding for the TIL award will be made for up to $200,000 per year (for a maximum of three years - total amount up to $600,000) including indirect costs. Funding for the third year is based on the successful submission of a non competitive progress report. The award amount will determined by the ALR’s Board of Directors based on the results of the peer review process including recommendations from the ALR’s Scientific Advisory Board. Detailed guidelines for application and submission are available on the websites listed above.
Deadlines associated with this grant program are as follows:
Letter of Intent: Due to ALR by June 25, 2013
Note : A non-binding letter of intent must be submitted by the investigator in advance of an invitation to apply for a grant. The letter must include a summary of the general theme and the potential future clinical ramification of the project future should it be successful. Submission of the LOI does not commit the investigator to submitting an application; however it is required to be submitted in order to have access to the full application. The main purpose of this letter is to assist the ALR’ s Scientific Advisory Board in determining whether the proposed subject matter of the proposal falls within the ALR’s particular research goals during the upcoming funding year.
Grant Applications: Due to ALR by August 1, 2013
The ALR funds research that will accelerate the development of new treatments for lupus. As such, grant proposals should be innovative in direction and utilize state-of-the-art techniques. Fundamental studies in genetics, immunology, cell biology and molecular biology to identify and characterize molecular systems must be oriented towards the development of drugs that would prevent and/or ameliorate clinical signs and symptoms of lupus.
Individuals with doctoral degrees (MD, PhD or equivalent) are eligible to apply. Scientific independence as evidenced by direction of a research program, a publication record, or other experience that establishes scientific leadership is necessary to apply. The ALR does not impose geographic restrictions on its applicants, and investigators working anywhere in the world are eligible and encouraged to apply. The ALR is willing to appropriately support research in industry or collaborations between academia and industry.
If you have any questions or require any additional information regarding the application process, please contact the ALR’s Research Administration department at 1-212-218-2840, 1-800-867-1743 or by e-mail at firstname.lastname@example.org.